RxDoctor Payments Data

Julia Jordan, NP

Nurse Practitioner · Wilmington, DENPI 1215362421

Payments from drug & device makers

$1,025in general payments, 2019–2025

Across 38 payments — averaging $26.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$187
  • Corium, LLC$160
  • Otsuka America Pharmaceutical, Inc.$154
  • AbbVie$127
  • Alkermes, Inc.$89
  • Takeda Pharmaceuticals U.S.A., Inc.$79
  • plus $230 from 6 others

What the payments were for

  • Food & beverage$1,025100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,025 in reported general payments places this provider in the 75th percentile of 487 nurse practitioner providers in Delaware.

See all nurse practitioner providers in Delaware

Medicare billing

Part B allowed, 2024
$7,698
Medicare patients
26
Services billed
92

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluvoxamine Maleate ErFluvoxamine Maleate12$4,986
Bupropion XlBupropion Hcl41$1,576
Duloxetine Hcl33$1,252
Quetiapine Fumarate20$814
Desvenlafaxine Succinate ErDesvenlafaxine Succinate16$648
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine22$562
Trazodone Hcl36$486
Venlafaxine Hcl ErVenlafaxine Hcl19$484
Fluoxetine Hcl28$376
Gabapentin24$339
Clonazepam35$335
Lamotrigine22$330
Hydroxyzine Pamoate15$301
Sertraline Hcl22$288
Aripiprazole12$257

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Wilmington

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →